Back to search
COPD III/IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which COPD III/IV trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which COPD III/IV trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Remimazolam is a new, ultra-short-acting benzodiazepine approved in Romania for procedural sedation. It shows significant clinical benefits compared to other se…
ADLIFE is a EU-funded project developing innovative digital health solutions to support healthcare planning and care delivery for patients with advanced chronic…